Comparison

GDC-0834

Item no. V4520-10mg
Manufacturer InvivoChem LLC
CASRN 1133432-49-1
Amount 10 mg
Quantity options 100 mg 250 mg 25 mg 50 mg 5 mg
Category
Type Biochemicals
Specific against other
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Description
InvivoChem Cat #:V4520CAS #:1133432-49-1Purity >=98%

Description: GDC-0834 (R-enantiomer) is a novel, potent and selective BTK inhibitor with an in vitro IC50 of 5.9 and 6.4 nM in biochemical and cellular assays, respectively, and in vivo IC50 of 1.1 and 5.6 uM in mouse and rat, respectively. Bruton's tyrosine kinase (BTK) plays a critical role in the development, differentiation, and proliferation of B-lineage cells, making it an attractive target for the treatment of rheumatoid arthritis. GDC-0834 inhibited BTK with an in vitro IC(50) of 5.9 and 6.4 nM in biochemical and cellular assays, respectively, and in vivo IC(50) of 1.1 and 5.6 uM in mouse and rat, respectively. Administration of GDC-0834 (30-100 mg/kg) in a rat collagen-induced arthritis (CIA) model resulted in a dose-dependent decrease of ankle swelling and reduction of morphologic pathology. An integrated disease progression pharmacokinetic/pharmacodynamic model where efficacy is driven by pBTK inhibition was fit to ankle-diameter time-course data. This model incorporated a transit model to characterize nondrug-related decreases in ankle swelling occurring at later stages of disease progression in CIA rats. The time course of ankle swelling in vehicle animals was described well by the base model. Simultaneous fitting of data from vehicle- and GDC-0834-treated groups showed that overall 73% inhibition of pBTK was needed to decrease the rate constant describing the ankle swelling increase (k(in)) by half. These findings suggest a high degree of pBTK inhibition is required for maximal activity of the pathway on inflammatory arthritis in rats.

References: 2011 Jul; 338(1):154-63; 2015 Jun; 43(6):908-15.

Related CAS : 1133432-49-1 (R-enantiomer); 1133432-46-8 (GDC-0834 Racemate); 1133432-50-4 (GDC-0834 S-enantiomer)

GDC-0834

Name: GDC-0834
CAS#: 1133432-49-1; 1133432-46-8 (racemate)
Chemical Formula: C33H36N6O3S
Exact Mass: 596.25696
Molecular Weight: 596.74
Elemental Analysis: C, 66.42; H, 6.08; N, 14.08; O, 8.04; S, 5.37
Storage
-20C for 3 years in powder form
-80C for 2 years in solvent
Technical Information
Synonym: GDC0834; GDC-0834; GDC 0834.
IUPAC/Chemical Name: (R)-N-(3-(6-((4-(1, 4-dimethyl-3-oxopiperazin-2-yl)phenyl)amino)-4-methyl-5-oxo-4, 5-dihydropyrazin-2-yl)-2-methylphenyl)-4, 5, 6, 7-tetrahydrobenzo[b]thiophene-2-carboxamide
InChi Key: CDOOFZZILLRUQH-GDLZYMKVSA-N
InChi Code: InChI=1S/C33H36N6O3S/c1-20-24(9-7-10-25(20)36-31(40)28-18-22-8-5-6-11-27(22)43-28)26-19-39(4)33(42)30(35-26)34-23-14-12-21(13-15-23)29-32(41)38(3)17-16-37(29)2/h7, 9-10, 12-15, 18-19, 29H, 5-6, 8, 11, 16-17H2, 1-4H3, (H, 34, 35)(H, 36, 40)/t29-/m1/s1
SMILES Code: O=C(C1=CC(CCCC2)=C2S1)NC3=CC=CC(C(N=C4NC5=CC=C([CH]6N(C)CCN(C)C6=O)C=C5)=CN(C)C4=O)=C3C

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close